Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cutaneous Squamous Cell Carcinoma: From Biology to Therapy
Roberto Corchado‐Cobos, Natalia García‐Sancha, Rogelio González‐Sarmiento, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2956-2956
Open Access | Times Cited: 164

Showing 26-50 of 164 citing articles:

Treatment of well-differentiated invasive squamous cell carcinoma of the skull and reconstruction by ultrathin anterolateral thigh flap
Edson Ramírez, José Bruno Mendoza Ramírez, Juan A. Ugalde, et al.
International Journal of Research in Medical Sciences (2025) Vol. 13, Iss. 2, pp. 841-844
Open Access
Cuando la mascarilla esconde un diagnóstico: carcinoma de células escamosas
Carlos M. de Castro, Patrícia Costa, Marta Àlvarez
Atención Primaria (2025) Vol. 57, Iss. 6, pp. 103230-103230
Closed Access
Dual cell-penetrating peptide-conjugated polymeric nanocarriers for miRNA-205-5p delivery in gene therapy of cutaneous squamous cell carcinoma
Cheng‐Yu Lin, Jia-You Fang, Chien‐Yu Hsiao, et al.
Acta Biomaterialia (2025)
Closed Access
Overexpression of lncRNA TINCR inhibits cutaneous squamous cell carcinoma cells through promotes methylation of Myc and TERC genes
Liang Wang, Yu Wang, Lei Xu
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Open Access
PD-L1 Inhibitor Cosibelimab for Cutaneous Squamous Cell Carcinoma: Comprehensive Evaluation of Efficacy, Mechanism, and Clinical Trial Insights
Omer A. Idris, Diana Westgate, Bahar Saadaie Jahromi, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 889-889
Open Access
The Purified Fraction of Persicaria capitata Flowers Attenuates Proliferation in A-431 Cell Lines
Vikrant Arya, Amandeep Kaur Gill, Yatendra Singh, et al.
Pharmacognosy Magazine (2025)
Closed Access
Expression of C1q by macrophages and fibroblasts in tumor microenvironment is associated with progression and metastasis of cutaneous squamous cell carcinoma
Kristina Viiklepp, Jaakko Knuutila, Liisa Nissinen, et al.
Journal of Investigative Dermatology (2025)
Open Access
Adjuvant therapy for high‐risk cutaneous squamous cell carcinoma: 10‐year review
Jason G. Newman, Mary A. Hall, Sarah J. Kurley, et al.
Head & Neck (2021) Vol. 43, Iss. 9, pp. 2822-2843
Open Access | Times Cited: 24
Drug repurposing: An emerging strategy in alleviating skin cancer
Popat Kumbhar, Kapil Kole, Tejashree Yadav, et al.
European Journal of Pharmacology (2022) Vol. 926, pp. 175031-175031
Closed Access | Times Cited: 18
Cemiplimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma: Appropriate Patient Selection and Perspectives
Layna Mager, Samantha Gardeen, David R. Carr, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 2135-2142
Open Access | Times Cited: 10
Expression Analysis of Retinal G Protein-coupled Receptor and its Correlation with Regulation of the Balance between Proliferation and Aberrant Differentiation in Cutaneous Squamous Cell Carcinoma
Jianglong Feng, Wei Zhang, Wen Zeng, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv13213-adv13213
Open Access | Times Cited: 3
E3 Ubiquitin Ligase NEDD4L Negatively Regulates Skin Tumorigenesis by Inhibiting IL-6/GP130 Signaling Pathway
Huan Liu, N Wang, Run Yang, et al.
Journal of Investigative Dermatology (2024)
Closed Access | Times Cited: 3
Triptolide Induces Apoptosis and Autophagy in Cutaneous Squamous Cell Carcinoma via Akt/mTOR Pathway
Zhe Zheng, Guorong Yan, Ningyuan Xi, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 13, pp. 1596-1604
Closed Access | Times Cited: 8
Cemiplimab treatment of squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa
Preslav Vasilev, Dimitar Kalev, Martin Karamanliev, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 3, pp. 295-297
Open Access | Times Cited: 7
The Role of Cell Adhesion Molecule 1 (CADM1) in Cutaneous Malignancies
Yu Sawada, Emi Mashima, Natsuko Saito‐Sasaki, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9732-9732
Open Access | Times Cited: 20
Daily Lifestyle and Cutaneous Malignancies
Yu Sawada, Motonobu Nakamura
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5227-5227
Open Access | Times Cited: 16
Exosomal Circular RNA RNA-seq Profiling and the Carcinogenic Role of Exosomal circ-CYP24A1 in Cutaneous Squamous Cell Carcinoma
Zheng Zhang, Hao Guo, Wen‐Jia Yang, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 16
Lidocaine represses proliferation and cisplatin resistance in cutaneous squamous cell carcinoma via miR-30c/SIRT1 regulation
Tao Liu, Fei Jiang, Liyuan Yu, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 6359-6370
Open Access | Times Cited: 12
A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review)
Benjamin Genenger, Jay R. Perry, Bruce Ashford, et al.
Discover Oncology (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Updates in Skin Cancer in Transplant Recipients and Immunosuppressed Patients: Review of the 2022–2023 Scientific Symposium of the International Immunosuppression and Transplant Skin Cancer Collaborative
Catherine Pisano, Justin J. Leitenberger, Melissa Pugliano‐Mauro, et al.
Transplant International (2024) Vol. 37
Open Access | Times Cited: 2
Comparative response to PDT with methyl-aminolevulinate and temoporfin in cutaneous and oral squamous cell carcinoma cells
Jimena Nicolás-Morala, Miguel Alonso-Juarranz, Ana Filipa Barahona, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Ex vivo therapeutic screening of metastatic cSCC: A review of methodological considerations for clinical implementation
Jessica Conley, Jay R. Perry, Bruce Ashford, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 4
Open Access | Times Cited: 2
Common skin cancers and their association with other non-cutaneous primary malignancies: a review of the literature
Lindsay Holic
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 2
Immunohistochemical Expression Levels of Epidermal Growth Factor Receptor, Cyclooxygenase-2, and Ki-67 in Canine Cutaneous Squamous Cell Carcinomas
João Luís, Rita Files, Cláudia Cardoso, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4951-4967
Open Access | Times Cited: 2
Natural product-loaded lipid-based nanocarriers for skin cancer treatment: An overview
Mithilesh Chaurasiya, Gaurav Kumar, Smita Paul, et al.
Life Sciences (2024) Vol. 357, pp. 123043-123043
Closed Access | Times Cited: 2

Scroll to top